By Dawood Fakhir ( September 26, 2025, 1:15 PM BST) -- Swiss biotech company Spineart SA said on Friday that it has raised 25 million Swiss francs ($31.2 million) from European private equity firms Gimv NV and EGS Beteiligungen AG to help it in its research and increase its global footprint....

See Full Page